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ABSTRACT
Objective: Cardiac autonomic neuropathy (CAN) is a severe and common, yet highly underdiagnosed, complication of Type 2 diabetes mellitus 
(T2DM). Subclinical CAN may have reduced heart rate variability (HRV) but normal Ewing battery test. This study was performed to evaluate the 
importance of 5 minutes HRV for the detection of autonomic dysfunction in T2DM without (CAN-T2DM).
Methods: This cross-sectional observational study was conducted at the Department of Physiology, Bangabandhu Sheikh Mujib Medical University 
(BSMMU) on 30 recently diagnosed T2DM (RT2DM) and 54 long-term CAN-male T2DM patients (LT2DM), aged 45-55 years, from the Endocrinology 
Out Patient Department of BSMMU, Dhaka. 30 age and body mass index matched apparently healthy male subjects were control. Ewing battery test 
was used to rule out CAN positive T2DM. HRV data were recorded by a polyrite-D and analyzed by software. HRV was assessed by time domain 
method. For statistical analysis, ANOVA and unpaired t-test were used.
Results: Mean RR, standard deviation of NN intervals (SDNN) (p<0.05), and root mean square of the successive differences (RMSSD) were significantly 
(p<0.001) lower, and mean HR and SDNN/RMSSD were (p<0.001) significantly higher in LT2DM compared to RT2DM and control. In addition, SDNN 
was also significantly (p<0.05) lower in RT2DM than that of control.
Conclusions: Results conclude that autonomic dysfunction may occur in both LT2DM and RT2DM patients without neuropathy and 5 minutes HRV 
test is an important tool for detecting subclinical CAN.
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INTRODUCTION
Diabetes mellitus (DM) affects 387 million people worldwide with 
higher prevalence in developing countries [1]. Type 2 DM (T2DM) is 
the most common form of DM and it is associated with multiple organic 
complications, including cardiac autonomic neuropathy (CAN) [2,3]. 
CAN has been extensively studied in T2DM due to its high prevalence, 
increased risk of cardiovascular mortality, and lack of established 
treatment until now [4].
CAN may be clinically evident or subclinical which is characterized by 
functional and reversible neuronal alteration; hence, it is potentially 
treatable condition if appropriate intervention is provided on 
time [4-6]. Subclinical stage of CAN could be detected only by test for 
autonomic nerve function [7].
The almost classical Ewing battery of five cardiovascular reflex tests 
has been widely used in diagnosing diabetic autonomic neuropathy. 
Nevertheless, these tests only detect symptomatic or clinical CAN [4,8] 
which may not be sensitive enough to detect subtle abnormalities in 
cardiac autonomic nerve activity [9].
Diabetic CAN represents one of only two recommended clinical utilities 
for heart rate variability (HRV) [10]. HRV has been suggested as one 
of the diagnostic tests for CAN in a recent statement of the American 
Diabetes Association [11]. HRV has been referred to as very accurate, 
noninvasive, and generally reproducible measurement technique, 
hence, could it be used as a marker for CAN [12].
However, conventionally available autonomic test (Ewing battery 
test) may appear normal during this stage of CAN [8]. In addition, 
Ewing battery test is a lengthy procedure and requires strict patient’s 
cooperation.
Recently, reduced HRV has been recognized as the earliest sign of 
CAN [9,11,13-17]. 5 minutes HRV test, such as 24 hrs HRV measurement, 
is a reliable, convenient, and economically practicable technique for 
detecting autonomic dysfunction [4,9-10,18]. Moreover, only a few 
studies have been conducted on T2DM patients through 5 minutes HRV 
analysis to explore the resting autonomic tone.
Duration of diabetes has an important effect on the degree of cardiac 
autonomic dysfunction associated with DM [19-25]. It may also be 
found at the time or within a year of diagnosis of T2DM [26,27].
Based on this backdrop, this study was designed to evaluate 5 minutes 
HRV measures through time domain method in both recently diagnosed 
and long-term T2DM (RT2DM and LT2DM) patients without CAN, thus, 
to explore the prospect of 5 minutes HRV test as a technique to detect 
subclinical CAN in T2DM.
METHODS
This cross-sectional observational study was carried out from January 
2015 to January 2016 at the Department of Physiology, Bangabandhu 
Sheikh Mujib Medical University (BSMMU), Dhaka. The protocol of the 
study was approved by the Institutional Review Board of BSMMU. For 
this study, 30 RT2DM (<6 months of duration of DM) [28] and 54LT2DM 
(5-10 years of duration of DM) [29] male patients were recruited 
from the Endocrinology Outpatient Department, BSMMU, after taking 
written informed consent. All of these patients were only under oral 
hypoglycemic agents in addition to lifestyle modifications, and none of 
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them had any symptom of CAN. All these patients were 45-55 years of 
age, 18.5-27 Kg/m² of body mass index (BMI) and 5-10% of hemoglobin 
A1c (HbA1c). 30 age and BMI matched nondiabetic apparently healthy 
male subjects were enrolled as controls. The patients who had history 
or were then suffering from: Diabetic retinopathy, hypertension 
(>140/90 mm Hg), coronary artery diseases, epilepsy, migraine, 
psychiatric disorders, respiratory disorders, hypo- and hyper-
thyroidism, consuming drugs with effect on autonomic nervous system 
function or who were current smokers, yoga practitioners, and athletes 
were excluded.
The patients who fulfilled the inclusion criteria then underwent a 
thorough physical examination and Ewing battery test in the Autonomic 
Lab, Department of Physiology, BSMMU. Based on autonomic 
nervous system scoring system, the patients who had normal or one 
borderline finding in these tests were considered to be CAN negative 
T2DM [14,29,30]. However, ones who had >1 borderline or ≥ abnormal 
finding were considered CAN positive T2DM patients [11,30,31], 
and  they were  excluded  from  the  study.  Subsequently,  CAN  ̶  patients 
underwent tests for fasting plasma glucose (PPG), 2 hrs PPG (2 hrs 
PPG), HbA1c, and plasma creatinine were performed to see glycemic 
status and to rule out nephropathy.
The finally selected patients were then given instructions to prepare 
for HRV recording. The night before HRV test: To finish their meal by 
09:00 PM, have sound sleep, avoid physical and mental stress, and 
refrain from drugs having effect on the central nervous system. The 
morning of HRV test day, they were advised to take light breakfast 
without coffee or tea.
On HRV test day, the room temperature of the Autonomic Lab was set 
to 25-28°C, and the patient was seated in the lab for 15 minutes before 
HRV recording allowing him to adjust with the lab environment. Then, 
the patient was requested to lie on the examination bed in supine 
position and to rest for 5 minutes more. After that, electrocardiogram 
was recorded on lead II for 5 minutes, by RMS multichannel polyrite-D, 
from which time domain measures of HRV was analyzed by polyrite 
software.
Data were expressed as mean and standard error of mean. For statistical 
analysis, one-way ANOVA and independent sample t-test were used as 
applicable. SPSS version 16 was used for data analysis. p<0.05 was 
taken as statistically significant level.
RESULTS
General characteristics of all subjects are presented in Table 1. BMI 
of RT2DM was significantly (p<0.05) higher than that of control and 
LT2DM, and pulse rate was significantly (p<0.05) increased in long-
term DM compared to control and recently diagnosed DM. There was 
a significant decrease in mean RR, root mean square of the successive 
differences (RMSSD), and standard deviation of NN intervals (SDNN) 
(p<0.001) in LT2DM compared to control and recently diagnosed ones, 
whereas the difference between the latter two groups was statistically 
not significant, except SDNN, which was also significantly lower in 
recently diagnosed DM compared to control (Figs. 1-3). Mean HR and 
SDNN/RMSSD (p<0.001) were significantly higher in LT2DM compared 
to control and RT2DM, and these values in the latter two groups were 
almost similar (Figs. 4 and 5).
DISCUSSION
In this study, SDNN, which reflects overall variability, derived from 
short-term HRV analysis was significantly reduced in RT2DM patients 
compared to controls and it was markedly reduced in DM patients with 
longer duration. Similar result was reported in previous studies which 
stated that there was decrease in overall variability of HR [9,24,32-34]. 
This demonstrates reduced overall HRV but with the greater degree of 
impairment in patients with longer duration of disease.
Again, notable decrease in mean RR, RMSSD, and variance in DM patients 
with longer duration confirmed the previous findings made by other 
researchers [9,24,32-34]. These results suggest marked impairment of 
Table 1: General characteristics of different groups (n=114)
Parameters Control (C) RT2DM LT2DM
Age (years) 48.5±0.50 48.54±0.60 49.78±0.38
BMI (kg/m2) 22.89±0.50 25.03±0.74* 23.17±0.19
Pulse rate (beats/min) 77.03±0.80 77.69±0.73 80.48±0.58#
SBP (mm Hg) 125.33±1.04 125.82±1.54 126.02±1.12
DBP (mm Hg) 77.0±0.88 78.65±0.81 78.61±0.69
FPG (mmol/L) 4.96±0.14 8.16±0.26¥ 7.67±0.14¥
2-hrs PPG (mmol/L) - 11.30±0.31 12.30±0.23
HbA1c (%) - 8.11±0.21ψ 7.18±0.07
*p<0.001 (RT2DM vs. LT2DM, C); #p<0.05 (LT2DM vs. RT2DM, C); 
¥p<0.05 (RT2DM, LT2DM vs. C); p<0.05 (LT2DM vs. RT2DM); ψp<0.001 (RT2DM 
vs. L2TDM). Data were expressed as mean±SEM. ANOVA and independent 
sample t-test were used. BMI: Body mass index, SBP: Systolic blood pressure, 
DBP: Diastolic blood pressure, RT2DM: Recently diagnosed Type 2 diabetes 
mellitus, LT2DM: Long-term Type 2 diabetes mellitus, SEM: Standard error of 
mean, FPG: Fasting plasma glucose, PPG: Plasma glucose, 
HbA1c: Hemoglobin A1c
Fig. 1: Mean±standard error of mean RR interval in different 
groups. RT2DM: Recently diagnosed Type 2 diabetes mellitus, 
LT2DM: Long-term Type 2 diabetes mellitus, C: Control, 
***p<0.001, LT2DM versus C; ###p<0.001, LT2DM versus RT2DM
Fig. 2: Mean±standard error of mean root mean square of the 
successive differences in different groups. RT2DM: Recently 
diagnosed Type 2 diabetes mellitus, LT2DM: Long-term 
Type 2 diabetes mellitus, C: Control, ***p<0.001, LT2DM versus C; 
###p<0.001, LT2DM versus RT2DM
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parasympathetic nerve function impairment and small involvement of 
sympathetic component in them. This is consistent with the statement, 
made by previous studies, that parasympathetic nerve discharge is 
decreased even at rest [34]. Nonetheless, these values in recently 
diagnosed group were almost similar to those of control indicating little 
effect in these patients as opposed to previous publication [32]. This 
might be due to the fact that unlike in this study, the T2DM patients 
with <2 years duration of DM was taken as RT2DM. Moreover, duration 
of DM has been said to have a significant association with the degree of 
autonomic dysfunction in many previous studies [19-25].
Mean HR, a representation of interaction between sympathetic 
and parasympathetic modulation of the heart, with predominant 
parasympathetic tone at rest [10], showed significant increment in 
LT2DM compared to control and recently diagnosed DM. This finding 
is consistent to previous finding [33]. Decreased parasympathetic 
nerve function might be responsible for increased HR as stated by the 
previous study [35]. This result suggests increased sympathetic nerve 
activity in LT2DM patients.
SDNN/RMSSD in literature has been used as a marker of autonomic 
balance [36], and it was significantly increased in LT2DM Group, 
denoting autonomic imbalance in LT2DM patients characterized by 
sympathetic overdrive.
It is important to note that all these previous studies, except the one 
conducted by Tarvainen et al., be it on LT2DM or RT2DM were done 
without ruling out the presence of CAN based on Ewing battery test [24].
The pathogenesis of CAN is still unclear, yet, hyperglycemia and 
hyperinsulinemia or insulin resistance induced neuronal damage seem 
to be the common area of focus among many researchers [26,36-38]. At 
early stage of CAN or during subclinical CAN, vagus nerve is the first to 
undergo damage resulting into sympathetic overactivity during which 
it may manifest with resting tachycardia and exercise intolerance, 
and abnormal findings in Ewing battery test [4]. During later stage, 
sympathetic denervation ensues, which may manifest with orthostatic 
hypotension [4].
In a nutshell, reduced HRV in both Groups of DM even in the absence 
of clinically evident autonomic neuropathy suggests the presence of 
autonomic dysfunction in its early stage. Moreover, there is greater 
impairment of parasympathetic component resulting into autonomic 
imbalance featured by sympathetic overdrive which is more evident in 
DM with longer duration.
The results in RT2DM provide a hint toward the initiation of autonomic 
disorder associated with the earliest stage of diabetes as said by 
previous studies that cardiac autonomic dysfunction could be present 
at the time of diagnosis or within a year of diagnosis of T2DM [26,27]. 
Nevertheless, the time period over which the subclinical CAN turns 
into clinical CAN or develops abnormal Ewing battery test is still 
uncertain [4]. Notwithstanding, subclinical CAN may manifest with 
reduced HRV, which is often undetected by the Ewing battery test, but 
detected HRV analysis [4,8].
Thus, it is noteworthy that all these evidence of autonomic dysfunction 
in its earliest stage could be traced only by short-term HRV.
CONCLUSIONS
Results of this study concluded that cardiac autonomic dysfunction 
was present in LT2DM patients without CAN (based on conventional 
autonomic test) characterized by predominant parasympathetic nerve 
function impairment and sympathetic overactivity. Moreover, subtle 
cardiac autonomic dysfunction occurs in RT2DM without CAN.
Hence, short-term HRV test is an essential technique for detection 
subclinical stage of CAN.
Fig. 3: Mean±standard error of mean standard deviation of NN 
intervals in different groups. RT2DM: Recently diagnosed Type 2 
diabetes mellitus, LT2DM: Long-term Type 2 diabetes mellitus, 
C: Control, ***p<0.001, LT2DM versus C; #p<0.05, LT2DM versus 
RT2DM, p<0.01, RT2DM versus C
Fig. 4: Mean±standard error of mean HR in different groups. 
RT2DM: Recently diagnosed Type 2 diabetes mellitus, LT2DM: 
Long-term Type 2 diabetes mellitus, C: Control, ***p<0.001, 
LT2DM versus C, ###p<0.05, LT2DM versus RT2DM
Fig. 5: Mean±standard error of mean standard deviation of NN 
intervals/root mean square of the successive differences in 
different groups. RT2DM: Recently diagnosed Type 2 diabetes 
mellitus, LT2DM: Long-term Type 2 diabetes mellitus, C: Control, 
***p<0.001, LT2DM versus C, ###p<0.05, LT2DM versus RT2DM
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